A 1.6-million-birth analysis finds that adoption of a 2016 trial's antibiotic protocol climbed sharply in US hospitals, with a drop in infection rates.
|Articles|February 12, 2008
ENHANCE study to affect utilization, not coverage, of cholesterol-lowering drugs
A survey of pharmacists and physicians at managed care companies finds that they believe Vytorin use will drop but coverage will remain the same.
Advertisement
Coverage of Vytorin and Zetia (ezetimibe, Merck/Schering-Plough) is not expected to change but utilization will drop, following the
Advertisement
Related to this article
New findings suggest semaglutide's benefits may extend well beyond diabetes and weight loss and into airway disease and mood disorders.
First approved for adults in 2022, the therapy is now cleared for adults and pediatric patients weighing 66 lbs or more with symptomatic obstructive hypertrophic cardiomyopathy.
With the inherent value medications provide in the greater health care system, Jennifer Hammons, PharmD, DrPH, argues that rural pharmacies deserve the proper recognition.
A claims analysis of 2031 patients aged 10 to 17 years found that nutrition counseling was infrequent and often began months after treatment started.
Community pharmacists offer accessible care, improve medication adherence, and build trust through education, vaccination support, and local health leadership.
Researchers compared vaccine coadministration with single-dose, sequential vaccination for the RSVPreF3 OA vaccine formulation in adults.
A study of women aged 50 to 69 years found that thrombotic risk varied by route of administration, estradiol dose, and duration of use.
Advertisement
Advertisement